SBUX vs MCD vs YUM
161 measures in 16 categories, one definition each, computed from filings and market data.
SBUX52.7
Starbucks Corporation
Consumer Cyclical · Restaurants
$97.52 +0.66%$111.2B mkt cap
Score DNA
MCD67.8
McDonald's Corporation
Consumer Cyclical · Restaurants
$242.97 +0.16%$171.9B mkt cap
Score DNA
Price, rebased to 100 three years ago
SBUX MCD YUM · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 2 | 6 | 1 |
| Last Congress purchase | 2026-06-05 | 2026-09-25 | 2026-03-27 |
| 13F net change in holders | +61 | −118 | −5 |
| ETFs adding shares, 30d | 1,326 | 1,521 | 1,153 |
| ETFs trimming, 30d | 1,095 | 1,246 | 978 |
| Net ETF funds, 30d | +231 | +275 | +175 |
Valuation
16 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| P/E (TTM) | 56.1x
81st
|
19.6x
30th
|
18.5x
26th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | 4.55
94th
|
1.09
47th
|
| Price / sales | 2.9x
74th
|
6.2x
100th
|
4.7x
90th
|
| Price / book | — | — | — |
| Price / tangible book | — | — | — |
| Price / free cash flow | 30.5x
81st
|
22.2x
42nd
|
24.5x
54th
|
| Price / operating cash flow | 22.3x
93rd
|
15.2x
62nd
|
19.7x
86th
|
| Enterprise value | $130.0B
97th
|
$225.7B
100th
|
$52.7B
94th
|
| EV / sales | 3.4x
71st
|
8.1x
100th
|
6.0x
94th
|
| EV / EBITDA | 21.9x
80th
|
15.0x
47th
|
17.9x
67th
|
| EV / EBIT | 30.3x
63rd
|
17.6x
37th
|
19.5x
41st
|
| EV / free cash flow | 35.7x
62nd
|
29.1x
38th
|
31.4x
50th
|
| Earnings yield | 1.8%
29th
|
5.1%
74th
|
5.4%
77th
|
| FCF yield | 3.3%
32nd
|
4.5%
65th
|
4.1%
55th
|
| Operating cash flow yield | 4.5%
13th
|
6.6%
42nd
|
5.1%
19th
|
| Graham number (per share) | — | — | — |
Profitability (TTM)
12 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Gross margin | 31.7%
65th
|
57.4%
97th
|
45.8%
90th
|
| EBITDA margin | 15.5%
65th
|
54.3%
100th
|
33.7%
97th
|
| Operating margin | 9.4%
45th
|
46.0%
100th
|
31.0%
97th
|
| EBIT margin | 11.2%
68th
|
46.2%
100th
|
31.0%
97th
|
| Net margin | 5.2%
58th
|
31.7%
100th
|
25.4%
97th
|
| NOPAT margin | 5.0%
29th
|
36.1%
100th
|
31.3%
97th
|
| FCF margin | 9.5%
65th
|
28.0%
100th
|
19.3%
97th
|
| Operating cash flow margin | 13.0%
52nd
|
41.0%
100th
|
23.9%
94th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 6.5%
26th
|
10.4%
55th
|
15.0%
77th
|
| Stock comp / revenue | 0.8%
61st
|
0.5%
32nd
|
0.5%
26th
|
| Effective tax rate | 47.1%
100th
|
21.4%
53rd
|
-0.9%
13th
|
Returns on capital
11 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| ROE (on average equity) | — | — | — |
| ROA | 6.4%
65th
|
14.7%
81st
|
28.4%
94th
|
| ROIC | 17.2%
71st
|
19.0%
81st
|
60.7%
97th
|
| ROCE | 23.3%
81st
|
22.9%
77th
|
61.6%
97th
|
| Return on tangible assets | 13.8%
71st
|
21.4%
84th
|
34.7%
94th
|
| Cash ROIC (OCF / invested capital) | 44.7%
90th
|
21.5%
63rd
|
46.4%
93rd
|
| Gross profitability (GP / assets) | 43.0%
71st
|
26.5%
55th
|
46.0%
74th
|
| ROIC, 3-yr average | 14.5%
75th
|
15.5%
79th
|
54.7%
96th
|
| ROIC, 5-yr average | — | — | — |
| ROE, 5-yr average | — | — | — |
| Incremental ROIC | -9.6%
39th
|
738.5%
97th
|
240.6%
90th
|
Growth
17 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Revenue growth (TTM YoY) | 4.5%
26th
|
6.3%
35th
|
10.3%
74th
|
| Revenue growth (QoQ) | -2.2%
16th
|
8.9%
74th
|
5.3%
42nd
|
| Revenue CAGR, 3 yr | 3.1%
33rd
|
4.6%
43rd
|
7.7%
57th
|
| Revenue CAGR, 5 yr | 7.2%
52nd
|
5.0%
40th
|
6.8%
48th
|
| Gross profit CAGR, 3 yr | 9.4%
57th
|
4.6%
40th
|
5.3%
43rd
|
| Operating income CAGR, 3 yr | -12.3%
16th
|
5.1%
36th
|
6.8%
40th
|
| Net income growth (TTM YoY) | -24.7%
28th
|
4.7%
48th
|
54.8%
84th
|
| Net income CAGR, 3 yr | -19.4%
17th
|
3.2%
29th
|
16.0%
75th
|
| EPS growth (TTM YoY) | -25.0%
28th
|
5.7%
44th
|
55.9%
80th
|
| EPS CAGR, 3 yr | -19.2%
17th
|
4.3%
33rd
|
17.0%
71st
|
| EPS CAGR, 5 yr | -6.2%
24th
|
6.1%
41st
|
12.6%
65th
|
| FCF growth (TTM YoY) | 61.6%
88th
|
12.5%
56th
|
9.3%
52nd
|
| FCF CAGR, 3 yr | 6.9%
48th
|
5.3%
38th
|
9.5%
57th
|
| Operating cash flow CAGR, 3 yr | -1.2%
29th
|
9.1%
50th
|
9.6%
54th
|
| Book value CAGR, 3 yr | — | — | — |
| Dividend CAGR, 3 yr | 1.3%
35th
|
2.6%
59th
|
2.4%
53rd
|
| Sustainable growth rate | — | — | — |
Margin history & stability
7 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Gross margin, 3-yr average | 27.7%
43rd
|
57.1%
100th
|
47.1%
90th
|
| Operating margin, 3-yr average | 12.1%
70th
|
45.7%
100th
|
31.7%
97th
|
| Net margin, 3-yr average | 7.8%
70th
|
32.1%
100th
|
21.8%
97th
|
| FCF margin, 3-yr average | 8.7%
67th
|
27.3%
100th
|
19.3%
97th
|
| Revenue stability (0-1) | 0.87
30th
|
0.98
73rd
|
0.92
47th
|
| Earnings stability (0-1) | 0.26
27th
|
0.74
57th
|
0.53
47th
|
| Margin stability (0-1) | 0.89
70th
|
0.97
90th
|
0.97
87th
|
Liquidity (latest quarter)
7 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Cash & short-term investments | $3.6B
100th
|
$822.0M
90th
|
$674.0M
87th
|
| Net cash (− = net debt) | −$18.8B
3rd
|
−$53.8B
0th
|
−$11.6B
10th
|
| Working capital | −$2.4B
0th
|
$327.0M
100th
|
−$1.8B
6th
|
| Current ratio | 0.76
42nd
|
1.08
61st
|
0.59
35th
|
| Quick ratio | 0.54
35th
|
1.07
61st
|
0.59
39th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.36
52nd
|
0.20
32nd
|
0.16
23rd
|
| Defensive interval (days) | 210 days
32nd
|
382 days
74th
|
368 days
68th
|
Leverage & solvency (latest quarter)
13 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Total debt | $22.4B
97th
|
$54.6B
100th
|
$12.3B
90th
|
| Debt / equity | — | — | — |
| Net debt / equity | — | — | — |
| Debt / assets | 79.3%
77th
|
91.1%
87th
|
141.4%
97th
|
| Debt / capital | — | — | — |
| Debt / EBITDA | 3.79
47th
|
3.63
43rd
|
4.17
60th
|
| Net debt / EBITDA | 3.18
43rd
|
3.58
53rd
|
3.94
60th
|
| Interest coverage (EBIT / interest) | 7.4x
59th
|
7.9x
63rd
|
5.3x
52nd
|
| Cash interest coverage | 8.6x
56th
|
7.0x
52nd
|
4.1x
33rd
|
| Debt payback (years of OCF) | 4.5 yrs
48th
|
4.8 yrs
52nd
|
5.9 yrs
66th
|
| Liabilities / assets | 127.1%
87th
|
101.7%
77th
|
181.9%
94th
|
| IS credit model rating | B- | A- | B- |
| Implied credit spread (bps) | 900
71st
|
175
16th
|
900
71st
|
Efficiency
11 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Asset turnover | 1.24
68th
|
0.46
16th
|
1.12
55th
|
| Fixed asset turnover | 2.56
71st
|
0.97
3rd
|
3.13
84th
|
| Inventory turnover | 11.7
0th
|
208.9
89th
|
— |
| Receivables turnover | 30.1
39th
|
11.0
6th
|
12.6
13th
|
| Days sales outstanding | 12 days
61st
|
33 days
94th
|
29 days
87th
|
| Days inventory outstanding | 31 days
100th
|
2 days
11th
|
— |
| Days payables outstanding | 26 days
65th
|
30 days
77th
|
93 days
100th
|
| Cash conversion cycle (days) | 18 days
97th
|
5 days
74th
|
−64 days
0th
|
| Capex / revenue | 3.5%
23rd
|
12.9%
90th
|
4.6%
39th
|
| Capex / depreciation | 0.82
16th
|
1.61
68th
|
1.71
71st
|
| Operating expense ratio | 59.1%
87th
|
11.0%
23rd
|
17.1%
50th
|
Cash flow & earnings quality
7 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Operating cash flow / net income | 2.51
56th
|
1.29
15th
|
0.94
7th
|
| FCF / net income | 1.84
85th
|
0.88
33rd
|
0.76
30th
|
| FCF / operating cash flow | 73.0%
79th
|
68.4%
72nd
|
80.6%
86th
|
| Capex / operating cash flow | 27.0%
21st
|
31.6%
28th
|
19.4%
14th
|
| Accruals ratio | -9.7%
26th
|
-4.3%
77th
|
1.7%
94th
|
| Sloan accruals ratio | -4.2%
68th
|
-5.4%
52nd
|
-20.3%
6th
|
| Earnings quality score (0-1) | 0.75
7th
|
1.00
78th
|
0.75
7th
|
Scores & forensic checks
15 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| IS score | 53
52nd
|
68
100th
|
62
90th
|
| IS profitability | 42
61st
|
72
97th
|
72
100th
|
| IS growth | 36
13th
|
58
55th
|
76
90th
|
| IS value | 32
23rd
|
48
68th
|
49
71st
|
| IS momentum | 58
26th
|
77
55th
|
81
68th
|
| IS risk (safety) | 80
65th
|
100
81st
|
50
23rd
|
| IS quality | 66
74th
|
77
100th
|
66
77th
|
| IS balance sheet | 41
48th
|
34
42nd
|
30
32nd
|
| IS earnings quality | 77
35th
|
82
65th
|
81
52nd
|
| IS cash flow | 65
84th
|
69
97th
|
57
65th
|
| Piotroski F-score (0-9) | 7
55th
|
8
87th
|
6
42nd
|
| Altman Z-score | 3.3
71st
|
4.7
81st
|
2.4
39th
|
| Beneish M-score | −3.32
10th
|
−2.30
74th
|
−2.53
65th
|
| Ohlson O-score | −5.30
74th
|
−7.65
13th
|
−1.93
90th
|
| IS credit score | 20
6th
|
68
77th
|
20
6th
|
Size (TTM)
8 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| Market cap | $111.2B
97th
|
$171.9B
100th
|
$41.1B
94th
|
| Revenue | $38.3B
100th
|
$27.7B
97th
|
$8.7B
81st
|
| EBITDA | $5.9B
97th
|
$15.0B
100th
|
$2.9B
94th
|
| Net income | $2.0B
94th
|
$8.8B
100th
|
$2.2B
97th
|
| Free cash flow | $3.6B
97th
|
$7.8B
100th
|
$1.7B
94th
|
| Total assets | $28.3B
97th
|
$59.9B
100th
|
$8.7B
81st
|
| Shareholders' equity | −$7.7B
0th
|
−$1.0B
10th
|
−$7.1B
3rd
|
| Employees | 381,000
100th
|
150,000
94th
|
49,000
65th
|
Price performance
9 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| 1 day | +0.7% | +0.2% | −0.2% |
| 1 week | +7.5% | +3.3% | +3.9% |
| 1 month | +0.9% | −2.2% | +10.9% |
| 3 months | −6.4% | −9.2% | +2.1% |
| 6 months | −1.4% | −22.0% | −7.5% |
| Year to date | +18.2% | −19.9% | +0.5% |
| 1 year | +20.7% | −19.9% | +4.6% |
| 3 years, cumulative | +14.4% | +2.1% | +32.8% |
| 5 years, cumulative | −1.3% | +8.1% | +32.2% |
Technicals
4 measures| Measure | SBUX | MCD | YUM |
|---|---|---|---|
| RSI 14 | 54.6 | 52.0 | 65.5 |
| From 52-week high | −11.2% | −28.5% | −11.5% |
| From 52-week low | +28.2% | +6.0% | +12.1% |
| Beta | 0.97 | 0.45 | 0.55 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17